NCT04485013 2026-02-18TTX-080 HLA-G Antagonist in Subjects With Advanced CancersTizona Therapeutics, IncPhase 1 Recruiting240 enrolled
NCT05887492 2025-11-18Study of TNG260 and an Anti-PD Antibody in STK11 Mutated Solid TumorsTango Therapeutics, Inc.Phase 1/2 Recruiting126 enrolled